SOLVE(D) | An IPG Health Company’s Post

I'm excited to share the success of our collaboration with CUTISS AG, a dynamic spin-off from the Zurich University of Applied Sciences and the University Children's Hospital Zurich. Together, Zühlke Group & CUTISS AG focused on automating the production of personalised bio-engineered skin for burns victims. Here’s what we achieved: Enhanced Efficiency and Precision: By integrating advanced technology, we significantly streamlined the production process. This means each skin graft is custom-made for the patient's needs, speeding up healing and reducing scarring. Power of Collaboration: This project truly underscored the strength of partnerships. By combining Zühlke's automation and tech expertise with CUTISS's innovative bio-engineered skin, we created a solution that exceeded expectations. Impact of Technology in Healthcare: Our work showcases how technology can transform healthcare. Automating the production of personalised skin grafts improves patient outcomes and simplifies complex medical procedures. Patient-Centred Solutions: With a strong focus on patient care, our more efficient and precise production process has led to better health outcomes for burns victims. This collaboration highlights how technology and strong partnerships drive meaningful advancements in healthcare. We're thrilled about our ongoing partnership with CUTISS and the positive impact it continues to make. Read the full story here: https://lnkd.in/dXkhuEjQ

I'm excited to share the success of our collaboration with CUTISS, a dynamic spin-off from the Zurich University of Applied Sciences and the University Children's Hospital Zurich. Together, Zühlke & Cutiss focused on automating the production of personalised bio-engineered skin for burns victims. Here’s what we achieved: Enhanced Efficiency and Precision: By integrating advanced technology, we significantly streamlined the production process. This means each skin graft is custom-made for the patient's needs, speeding up healing and reducing scarring. Power of Collaboration: This project truly underscored the strength of partnerships. By combining Zühlke's automation and tech expertise with CUTISS's innovative bio-engineered skin, we created a solution that exceeded expectations. Impact of Technology in Healthcare: Our work showcases how technology can transform healthcare. Automating the production of personalised skin grafts improves patient outcomes and simplifies complex medical procedures. Patient-Centred Solutions: With a strong focus on patient care, our more efficient and precise production process has led to better health outcomes for burns victims. This collaboration highlights how technology and strong partnerships drive meaningful advancements in healthcare. We're thrilled about our ongoing partnership with CUTISS and the positive impact it continues to make. Read the full story here: https://lnkd.in/dtuaHThb

🆕Dealflow.eu’s next Multicorporate #Matchmaking Event, dedicated to #Health & #Medical #Technologies, is coming soon!     📅The event will be held on 6th November and will be hosted by EurA AG.    👥The goal of the matchmaking event is to bring together EU-funded #innovators and #Corporates headquartered in the #EU to foster collaboration on different levels.     🚀The possible long-term outcomes of the event are:   - Collaboration for further technological development.   - #Piloting of products/solutions.   - Purchase of solution by #corporate.   - #Investment relation.     👉 A big thanks to CUF - Hospitais e Clínicas and Siemens Healthineers for joining us!   🔜More details coming soon!    📢 If you are an EU-funded #innovator and you would like to participate in this Multicorporate Matchmaking Event, apply here until September 18:  https://lnkd.in/d-Curxxj  

That’s a wrap for #MedTech2024 in #Toronto! What an exciting few days of #innovation and #networking in the #healthcare space. With over 3,500 innovators and 1,800+ medtech companies from 45+ countries, it was inspiring to see the future of medical technology in action here at The MedTech Conference! Also, the Ontario Government | Gouvernement de l’Ontario unveiled the next phase of its life sciences strategy at #Medtech aimed at driving #innovation, boosting investments and enhancing research to further solidify the province as a global leader in #biomanufacturing and #healthsciences. 💲💲This includes a $146 million investment to help fuel the sector’s growth. 👏👏 Some key observations: 🔬 AI-Powered Healthcare: AI is transforming diagnostics and treatment planning at an incredible pace. The future is here! 🤝 Collaborative Ecosystems: Partnerships between startups, big pharma, and tech giants are stronger than ever, driving breakthrough solutions. 🏥 Patient-Centered Innovation: From personalized treatments to wearable tech, patient needs are shaping product development. 🌍 Global Health Equity: Innovators are prioritizing access, ensuring that cutting-edge solutions reach underserved communities. 🚀 Regulatory Challenges: As technology advances, policies and frameworks will need to evolve quickly to keep up. Kudos to John Preece for all his work in the City of Toronto’s Life Sciences space and to all the speakers for sharing their very rich and enlightening insights! Thanks Destination Toronto and Invest Ontario for bringing #Medtechcon to #Toronto Excited to see how these trends will shape healthcare’s future! #HealthcareInnovation #TorontoMedTech Patrick Tobin Clare Barnett Victor Fedeli Shelley Carroll, ICD.D Andrew Weir Stephen Lund ICD.D Michael Fedchyshyn Leslie Fink John Preece Sarah Garringer, M.B.A. Sophia Yue Li University Health Network MaRS Discovery District Invest Ontario City of Toronto City of Toronto- Business and Economy Toronto Global Toronto Region Board of Trade

I'm excited to share the success of our collaboration with CUTISS, a dynamic spin-off from the Zurich University of Applied Sciences and the University Children's Hospital Zurich. Together, Zühlke & Cutiss focused on automating the production of personalised bio-engineered skin for burns victims. Here’s what we achieved: Enhanced Efficiency and Precision: By integrating advanced technology, we significantly streamlined the production process. This means each skin graft is custom-made for the patient's needs, speeding up healing and reducing scarring. Power of Collaboration: This project truly underscored the strength of partnerships. By combining Zühlke's automation and tech expertise with CUTISS's innovative bio-engineered skin, we created a solution that exceeded expectations. Impact of Technology in Healthcare: Our work showcases how technology can transform healthcare. Automating the production of personalised skin grafts improves patient outcomes and simplifies complex medical procedures. Patient-Centred Solutions: With a strong focus on patient care, our more efficient and precise production process has led to better health outcomes for burns victims. This collaboration highlights how technology and strong partnerships drive meaningful advancements in healthcare. We're thrilled about our ongoing partnership with CUTISS and the positive impact it continues to make. Read the full story here: https://lnkd.in/eAbvFp7P

Ever wondered what fuels relentless growth and sharpens the edge of innovation? Today, we unlock a new chapter at Vaxa with the launch of our new Australian headquarters. But it’s more than just an office; it’s a gateway to possibilities, where questions like 'How can we drive your success further?' and 'What makes your organisation tick?' Why not visit? Are you ready to see how coffee, tea, or champagne can mark the beginning of our journey together? How can we help in Identifying, Analysing, Strategising, and Growing your business or organisation using our unique technology, systems, and processes? Our expertise? Analytics, Network Architecture, Strategy, Solution Design, Project Delivery. But what does this mean for you? How can we tailor these to fit your unique path to success? Vaxa is operating Australia, the United States, and India, we're asking: Where will your next breakthrough come from? How ready are you to explore new horizons? www.vaxagroup.com #VaxaGroup #BusinessGrowth #InnovationLeaders #StrategyAndGrowth #AnalyticsExperts #NetworkArchitecture #SolutionDesign #ProjectDelivery #GlobalExpansion #AustralianBusiness

I'm excited to share the success of our collaboration with CUTISS, a dynamic spin-off from the Zurich University of Applied Sciences and the University Children's Hospital Zurich. Together, Zühlke & Cutiss focused on automating the production of personalised bio-engineered skin for burns victims. Here’s what we achieved: Enhanced Efficiency and Precision: By integrating advanced technology, we significantly streamlined the production process. This means each skin graft is custom-made for the patient's needs, speeding up healing and reducing scarring. Power of Collaboration: This project truly underscored the strength of partnerships. By combining Zühlke's automation and tech expertise with CUTISS's innovative bio-engineered skin, we created a solution that exceeded expectations. Impact of Technology in Healthcare: Our work showcases how technology can transform healthcare. Automating the production of personalised skin grafts improves patient outcomes and simplifies complex medical procedures. Patient-Centred Solutions: With a strong focus on patient care, our more efficient and precise production process has led to better health outcomes for burns victims. This collaboration highlights how technology and strong partnerships drive meaningful advancements in healthcare. We're thrilled about our ongoing partnership with CUTISS and the positive impact it continues to make. Read the full story here: https://lnkd.in/gqv2crF3

Catch the highlights of an exclusive interview with Delnaaz Irani, Associate Director at GSK hosted by Simran Shiwalkar from CIO News, at the EmergeTech Multicity Roadshow in Mumbai. Discover insights on tech innovation and industry trends! 🚀 . . . #EmergeTech #DelnaazIrani #SimranShiwalkar #TechTalks #MumbaiTechEvent #GSK #CIONews”

Unlock the potential of the Swiss life sciences hub, where global giants and visionary startups converge for unparalleled growth: - Innovation Nexus: Nestled in Europe's heart, Switzerland thrives as a dynamic Med-Device and Digital Health powerhouse. 14,000+ companies specialize in cutting-edge technologies, from biomaterials to automation. - Talent & Productivity: Boasting the highest work productivity in the industry, Switzerland attracts top-notch scientists and hosts 110,000+ skilled professionals. - Capital Magnet: With over $900 million invested and strategic partnerships flourishing, Switzerland provides an outstanding framework for securing capital and fostering growth. - Biotech Powerhouse: Strong research, a supportive regulatory environment, and intellectual property protection make Switzerland a go-to destination for biopharma innovation. - Success Stories: Explore breakthroughs from industry leaders like Novartis, Roche, Merck (MSD), and rising stars such as Artbio and Apellis. Ready to propel your health tech venture in Switzerland? Contact Business Location Switzerland, your gateway to success! https://bit.ly/48nq3Z4 #ad #BusinessLocationSwitzerland #SwissInnovation #HealthTech #WhySwitzerland

There are only 7 days left until We.Conect, Berlin begins and we cannot wait.  With a lineup of insightful sessions, networking opportunities, and thought-provoking discussions, We.Conect promises to be an unmissable experience.  See you in Berlin!    #MES #ManufacturingExecutionSystems #DigitalTransformation #PharmaMES #PharmaMESBerlin